# Forrester Research, Inc.: overview FORR · Nasdaq · CIK 1023313 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/forr.md) · [Financials](/companies/forr/financials.md) · [Filings](/companies/forr/filings.md) · [Insiders](/companies/forr/insiders.md) Latest reported revenue: [$100.2m](/filings/0001193125-26-336932.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-336932). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [103](/filings/0001193125-25-274219.md) | [108 d](/filings/0001193125-26-105114.md) | [89.9](/filings/0001193125-26-213464.md) | [112](/filings/0001193125-26-336932.md) | [94.3](/filings/0001193125-25-274219.md) | [101 d](/filings/0001193125-26-105114.md) | [85.5](/filings/0001193125-26-213464.md) | [100](/filings/0001193125-26-336932.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(0.7%)](/filings/0001193125-25-274219.md) | [(0.5%) d](/filings/0001193125-26-105114.md) | [(97.5%)](/filings/0001193125-26-213464.md) | [6.2%](/filings/0001193125-26-336932.md) | [4.7%](/filings/0001193125-25-274219.md) | [(36.6%) d](/filings/0001193125-26-105114.md) | [(21.8%)](/filings/0001193125-26-213464.md) | [3.4%](/filings/0001193125-26-336932.md) | | Net margin | % | [(5.7%)](/filings/0001193125-25-274219.md) | [0.4% d](/filings/0001193125-26-105114.md) | [(97.1%)](/filings/0001193125-26-213464.md) | [3.5%](/filings/0001193125-26-336932.md) | [(2.3%)](/filings/0001193125-25-274219.md) | [(33.5%) d](/filings/0001193125-26-105114.md) | [(25.5%)](/filings/0001193125-26-213464.md) | [15.2%](/filings/0001193125-26-336932.md) | | Diluted EPS | $ per share | [(0.30)](/filings/0001193125-25-274219.md) | not reported | [(4.62)](/filings/0001193125-26-213464.md) | [0.20](/filings/0001193125-26-336932.md) | [(0.11)](/filings/0001193125-25-274219.md) | not reported | [(1.14)](/filings/0001193125-26-213464.md) | [0.78](/filings/0001193125-26-336932.md) | | Free cash flow | $m | [(0.2) d](/filings/0001193125-25-274219.md) | [(2.5) d](/filings/0001193125-26-105114.md) | [26.1](/filings/0001193125-26-213464.md) | [(4.2) d](/filings/0001193125-26-336932.md) | [0.5 d](/filings/0001193125-25-274219.md) | [(4.3) d](/filings/0001193125-26-105114.md) | [19.4](/filings/0001193125-26-213464.md) | [(12.6) d](/filings/0001193125-26-336932.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [494](/filings/0000950170-24-028381.md) | [538](/filings/0000950170-25-035158.md) | [481](/filings/0001193125-26-105114.md) | [432](/filings/0001193125-26-105114.md) | [397](/filings/0001193125-26-105114.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [7.8%](/filings/0000950170-24-028381.md) | [6.1%](/filings/0000950170-25-035158.md) | [1.4%](/filings/0001193125-26-105114.md) | [0.2%](/filings/0001193125-26-105114.md) | [(28.5%)](/filings/0001193125-26-105114.md) | | Net margin | % | [5.0%](/filings/0000950170-24-028381.md) | [4.1%](/filings/0000950170-25-035158.md) | [0.6%](/filings/0001193125-26-105114.md) | [(1.3%)](/filings/0001193125-26-105114.md) | [(30.1%)](/filings/0001193125-26-105114.md) | | Diluted EPS | $ per share | [1.28](/filings/0000950170-24-028381.md) | [1.14](/filings/0000950170-25-035158.md) | [0.16](/filings/0001193125-26-105114.md) | [(0.30)](/filings/0001193125-26-105114.md) | [(6.28)](/filings/0001193125-26-105114.md) | | Free cash flow | $m | [96.3](/filings/0000950170-24-028381.md) | [33.8](/filings/0000950170-25-035158.md) | [16.2](/filings/0001193125-26-105114.md) | [(7.3)](/filings/0001193125-26-105114.md) | [18.1](/filings/0001193125-26-105114.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/forr/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Portolan Capital Management, LLC](/funds/1350290.md) | 2026-06-30 | $13.7m | 1,623,925 | | Added +82,649 | | [Nantahala Capital Management, LLC](/funds/1472322.md) | 2026-06-30 | $6.4m | 763,446 | | Added +69,024 | | [Nantahala Capital Management, LLC](/funds/1472322.md) | 2026-06-30 | $6.4m | 763,446 | | Added +69,024 | | [FIRST MANHATTAN CO. LLC.](/funds/728083.md) | 2026-06-30 | $6.3m | 750,000 | | Unchanged | | [Pacific Ridge Capital Partners, LLC](/funds/1591546.md) | 2026-06-30 | $5.9m | 705,344 | | Reduced −5,503 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $4.2m | 500,395 | | Added +13,473 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $3.5m | 418,206 | | Reduced −18,500 | | [HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC](/funds/1164833.md) | 2026-06-30 | $3.1m | 366,689 | | Reduced −16,900 | | [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $3.0m | 357,665 | | Added +171,743 | | [Quantinno Capital Management LP](/funds/1759654.md) | 2026-06-30 | $2.4m | 289,195 | | Added +65,110 | ## Recent filings [All 1,231 filings](/companies/forr/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-29 | 16:05 ET | [8-K](/filings/0001193125-26-437770.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-437770 | | 2026-08-06 | 08:52 ET | [10-Q](/filings/0001193125-26-336932.md) | Quarterly report, period 2026-06-30 | 0001193125-26-336932 | | 2026-07-30 | 16:02 ET | [8-K](/filings/0001193125-26-326088.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-326088 | | 2026-05-13 | 16:05 ET | [8-K](/filings/0001193125-26-221590.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-221590 | | 2026-05-08 | 09:04 ET | [10-Q](/filings/0001193125-26-213464.md) | Quarterly report, period 2026-03-31 | 0001193125-26-213464 | | 2026-05-06 | 16:05 ET | [8-K](/filings/0001193125-26-208920.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-208920 | | 2026-03-31 | 11:43 ET | [DEF 14A](/filings/0001193125-26-133728.md) | Proxy statement, period 2026-05-12 | 0001193125-26-133728 | | 2026-03-13 | 08:42 ET | [10-K](/filings/0001193125-26-105114.md) | Annual report, period 2025-12-31 | 0001193125-26-105114 | | 2026-02-12 | 16:05 ET | [8-K](/filings/0001193125-26-048685.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-048685 | | 2026-02-09 | 16:05 ET | [8-K](/filings/0001193125-26-042776.md) | 2.05 Exit or disposal costs | 0001193125-26-042776 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-105114.md), filed Mar 13, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/93600224-bda0-4c0a-a749-0cd8ee100a2f) ## About the filer - CIK: 1023313 - Tickers: FORR - Exchange: Nasdaq - SIC code: 8700 Services-Engineering, Accounting, Research, Management - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:06 ET. No prices; not investment advice.